Paper33333772
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
Petrosino S and 1 other. Int J Mol Sci, 2020. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review. Papers, record 33333772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33333772
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amides | Major topic |
| Ethanolamines | Major topic |
| Inflammation | Major topic |
| Nervous System Diseases | Major topic |
| Neurodegenerative Diseases | Major topic |
| Palmitic Acids | Major topic |
| Alzheimer Disease | |
| Amyotrophic Lateral Sclerosis | |
| Animals | |
| Autism Spectrum Disorder | |
| Endocannabinoids | |
| Humans | |
| Metabolic Networks and Pathways | |
| Multiple Sclerosis | |
| Pain | |
| Parkinson Disease |
Source PubMed
References172
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15465922 | The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. | Mol Pharmacol | 2005 | https://conductscience.org/library/papers/15465922 | PubMed |
| 2 | 22845893 | Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis. | Pain Med | 2012 | https://conductscience.org/library/papers/22845893 | PubMed |
| 3 | 32377286 | Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study. | Pain Res Manag | 2020 | https://conductscience.org/library/papers/32377286 | PubMed |
| 4 | 31863365 | Combination of Rehabilitative Therapy with Ultramicronized Palmitoylethanolamide for Chronic Low Back Pain: An Observational Study. | Pain Ther | 2020 | https://conductscience.org/library/papers/31863365 | PubMed |
| 5 | 17196922 | Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry. | Anal Biochem | 2007 | https://conductscience.org/library/papers/17196922 | PubMed |
| 6 | 9498819 | Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma. | FEBS Lett | 1998 | https://conductscience.org/library/papers/9498819 | PubMed |
| 7 | 32033363 | Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease. | J Clin Med | 2020 | https://conductscience.org/library/papers/32033363 | PubMed |
| 8 | 29246232 | Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia. | J Neuroinflammation | 2017 | https://conductscience.org/library/papers/29246232 | PubMed |
| 9 | 8931279 | Nerve growth factor: from neurotrophin to neurokine. | Trends Neurosci | 1996 | https://conductscience.org/library/papers/8931279 | PubMed |
| 10 | 23862567 | Polydatin: a review of pharmacology and pharmacokinetics. | Pharm Biol | 2013 | https://conductscience.org/library/papers/23862567 | PubMed |
| 11 | 27701827 | Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism. | CNS Neurosci Ther | 2017 | https://conductscience.org/library/papers/27701827 | PubMed |
| 12 | 25686754 | The role of inflammation in perinatal brain injury. | Nat Rev Neurol | 2015 | https://conductscience.org/library/papers/25686754 | PubMed |
| 13 | 23231720 | Neuroinflammation in autism spectrum disorders. | J Neuroinflammation | 2012 | https://conductscience.org/library/papers/23231720 | PubMed |
| 14 | 28594885 | Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome. | PLoS One | 2017 | https://conductscience.org/library/papers/28594885 | PubMed |
| 15 | 29576849 | Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/29576849 | PubMed |
| 16 | 10440374 | Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. | Nature | 1999 | https://conductscience.org/library/papers/10440374 | PubMed |
| 17 | 24677570 | Classical endocannabinoid-like compounds and their regulation by nutrients. | Biofactors | 2014 | https://conductscience.org/library/papers/24677570 | PubMed |
| 18 | 31427928 | Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome. | Front Cell Neurosci | 2019 | https://conductscience.org/library/papers/31427928 | PubMed |
| 19 | 32808580 | Sepsis-associated encephalopathy and septic encephalitis: an update. | Expert Rev Anti Infect Ther | 2021 | https://conductscience.org/library/papers/32808580 | PubMed |
| 20 | 29615912 | Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29615912 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42837101 | Enhancing meloxicam efficacy in acute and chronic inflammatory pain: a novel dose-sparing approach using ultramicronized palmitoylethanolamide. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42837101 | PubMed |
| 42812398 | ALIAmides and pediatric health: a structured narrative review. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42812398 | PubMed |
| 42796932 | Palmitoylethanolamide and Luteolin in Brain Aging and Cognitive Decline: Biological Rationale and Current Evidence. | Nutrients | 2026 | https://conductscience.org/library/papers/42796932 | PubMed |
| 42255791 | Water-Dispersible Palmitoylethanolamide (PEA) Supplementation for Functional Improvement in Adults With Chronic Sciatica-Related Back Pain: A Pilot Clinical Trial. | Cureus | 2026 | https://conductscience.org/library/papers/42255791 | PubMed |
| 42198460 | New Adjuvant Therapies for Obesity-Related Disorders Associated with Meta-Neuroinflammation. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198460 | PubMed |
| 42038098 | The Effects of Palmitoylethanolamide or Ibuprofen on the Abundance Profile and Synthesis Rate of Proteins in C2C12 Skeletal Myotubes. | FASEB Bioadv | 2026 | https://conductscience.org/library/papers/42038098 | PubMed |
| 41751904 | Gut-Brain Inflammation and Disrupted Homeostasis Due to Activation of Mast Cells and Microglia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751904 | PubMed |
| 41550956 | The immunomodulating effect of palmitoylethanolamide on human myeloid dendritic cells and its possible impact on Alzheimer's disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/41550956 | PubMed |
| 41303442 | The Endocannabinoid-Microbiota-Neuroimmune Super-System: A Unifying Feedback Architecture for Systems Resilience, Collapse Trajectories, and Precision Feedback Medicine. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303442 | PubMed |
| 40981167 | Evaluation of the Clinical Efficacy of a Novel Palmitoylethanolamide-Equisetum arvense Supplement for the Management of Chronic Pain: Findings from a Prospective Clinical Trial. | Med Sci (Basel) | 2025 | https://conductscience.org/library/papers/40981167 | PubMed |
| 40800112 | Microbiome and metabolome integrated analysis: exploring potential diagnostic approaches for Parkinson's disease using tongue coating samples. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40800112 | PubMed |
| 40596256 | Deciphering the interaction between N-palmitoyl-D-glucosamine and the endocannabinoidome. | Sci Rep | 2025 | https://conductscience.org/library/papers/40596256 | PubMed |
| 39839988 | Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations. | Brain Behav Immun Health | 2025 | https://conductscience.org/library/papers/39839988 | PubMed |
| 39630391 | A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review. | Pain Ther | 2025 | https://conductscience.org/library/papers/39630391 | PubMed |
| 39502301 | Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases. | Front Psychiatry | 2024 | https://conductscience.org/library/papers/39502301 | PubMed |
| 39201765 | Palmitoylethanolamide as a Supplement: The Importance of Dose-Dependent Effects for Improving Nervous Tissue Health in an In Vitro Model. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201765 | PubMed |
| 39086469 | Novel drug treatments for pain in advanced cancer and serious illness: a focus on neuropathic pain and chemotherapy-induced peripheral neuropathy. | Palliat Care Soc Pract | 2024 | https://conductscience.org/library/papers/39086469 | PubMed |
| 38892586 | Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis. | Nutrients | 2024 | https://conductscience.org/library/papers/38892586 | PubMed |
| 38844675 | The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial. | Sports Med Open | 2024 | https://conductscience.org/library/papers/38844675 | PubMed |
| 38792328 | Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain Related to Chronic Inflammatory Demyelinating Polyneuropathy: A Proof-of-Concept Study. | J Clin Med | 2024 | https://conductscience.org/library/papers/38792328 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33333772
GET https://conductscience.org/api/papers/v1/33333772/references?page=2